Company Overview
ARBUTUS BIOPHARMA CORP
ABUSRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
14M
2025 FY
Net Income
-34M
2025 FY
Shares Outstanding
192M
2025 FY
EPS
-0.17USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1447028
Exchange
Nasdaq
Location
CA